Home » Topics » BioWorld Science

BioWorld Science
RSS

Axis Genetics scales up CVP production in anticipation of clinical trials

May 10, 1996

Jenner Technologies in-licenses MTP-PE from Ciba

May 10, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

ALX40-4C blocks HIV infection

May 10, 1996

DaunoXome launched in U.S. for HIV-related KS

May 10, 1996

Ribozyme treatment of HIV-1-infected patients

May 10, 1996

Saquinavir combinations under clinical evaluation

May 10, 1996

DuPont Merck discloses HIV protease inhibitors

May 10, 1996

Academic investigators report potential anti-HIV agents

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...